tiprankstipranks
Denali Therapeutics (DE:4DN)
FRANKFURT:4DN
Germany Market

Denali Therapeutics (4DN) Blogger Opinions & Sentiment

7 Followers

Blogger Sentiment

Neutral 50.00%
Sector Average
Neutral
DE:4DN Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
33% SeekingAlpha
33% Zacks
16% Investing
18% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Baillie Gifford Trims Denali Therapeutics (DNLI) Stake in June Reduction
GuruFocus
DNLI Q2 Loss Narrows; Avlayah Sales Drive Strong Launch Momentum
Zacks
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Denali Therapeutics: 'Strong Buy' On AVLAYAH Approval And End Of 2026 FTD-GRN Data
SeekingAlpha
JPMorgan resumes Denali Therapeutics stock coverage with Overweight rating
Investing
Denali: Regulatory Delay Is A Strategic Opportunity
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of DE:4DN?
Seeking Alpha’s Terry Chrisomalis has a Bullish Sentiment.
    What do Motley Fool contributors think of DE:4DN?
    Currently there's no blogger sentiment for DE:4DN.
    What Is DE:4DN’s Blogger Sentiment?
    DE:4DN’s Blogger Sentiment is Neutral.
      What was the most recent blogger prediction for DE:4DN?
      The most recent blogger prediction for DE:4DN was made by Ekta Bagri, who was Neutral on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          DFTXDefinium Therapeutics
          TGTXTG Therapeutics
          PGENPrecigen